Anesth Analg 2007;105:562-569
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000278083.31991.36
CARDIOVASCULAR ANESTHESIA
Noble Gases Without Anesthetic Properties Protect Myocardium Against Infarction by Activating Prosurvival Signaling Kinases and Inhibiting Mitochondrial Permeability Transition In Vivo
Paul S. Pagel, MD, PhD* ,
John G. Krolikowski, BS*,
Yon Hee Shim, MD*,
Suneetha Venkatapuram, MD ,
Judy R. Kersten, MD* ,
Dorothee Weihrauch, DVM, PhD*,
David C. Warltier, MD, PhD*  , and
Phillip F. Pratt, Jr, PhD*
From the *Department of Anesthesiology, The Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin; Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin; and Departments of Medicine (Division of Cardiovascular Diseases) and Pharmacology and Toxicology, The Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin.
Address correspondence and reprint requests to Paul S. Pagel, MD, PhD, Clement J. Zablocki Veterans Affairs Medical Center, 5000 W. National Avenue, Milwaukee, WI 53295. Address e-mail to pspagel{at}mcw.edu.
BACKGROUND: The anesthetic noble gas, xenon, produces cardioprotection. We hypothesized that other noble gases without anesthetic properties [helium (He), neon (Ne), argon (Ar)] also produce cardioprotection, and further hypothesized that this beneficial effect is mediated by activation of prosurvival signaling kinases [including phosphatidylinositol-3-kinase, extracellular signal-regulated kinase, and 70-kDa ribosomal protein s6 kinase] and inhibition of mitochondrial permeability transition pore (mPTP) opening in vivo.
METHODS: Rabbits (n = 98) instrumented for hemodynamic measurement and subjected to a 30-min left anterior descending coronary artery (LAD) occlusion and 3 h reperfusion received 0.9% saline (control), three cycles of 70% He-, Ne-, or Ar-30% O2 administered for 5 min interspersed with 5 min of 70% N2–30% O2 before LAD occlusion, or three cycles of brief (5 min) ischemia interspersed with 5 min reperfusion before prolonged LAD occlusion and reperfusion (ischemic preconditioning). Additional groups of rabbits received selective inhibitors of phosphatidylinositol-3-kinase (wortmannin; 0.6 mg/kg), extracellular signal-regulated kinase (PD 098059; 2 mg/kg), or 70-kDa ribosomal protein s6 kinase (rapamycin; 0.25 mg/kg) or mPTP opener atractyloside (5 mg/kg) in the absence or presence of He pretreatment.
RESULTS: He, Ne, Ar, and ischemic preconditioning significantly (P < 0.05) reduced myocardial infarct size [23% ± 4%, 20% ± 3%, 22% ± 2%, 17% ± 3% of the left ventricular area at risk (mean ± sd); triphenyltetrazolium chloride staining] versus control (45% ± 5%). Wortmannin, PD 098059, rapamycin, and atractyloside alone did not affect infarct size, but these drugs abolished He-induced cardioprotection.
CONCLUSIONS: The results indicate that noble gases without anesthetic properties produce cardioprotection by activating prosurvival signaling kinases and inhibiting mPTP opening in rabbits.
This article has been cited by other articles:

|
 |

|
 |
 
J. Frassdorf, S. De Hert, and W. Schlack
Anaesthesia and myocardial ischaemia/reperfusion injury
Br. J. Anaesth.,
July 1, 2009;
103(1):
89 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lucchinetti, J. Wacker, C. Maurer, M. Keel, L. Harter, K. Zaugg, and M. Zaugg
Helium Breathing Provides Modest Antiinflammatory, but No Endothelial Protection Against Ischemia-Reperfusion Injury in Humans In Vivo
Anesth. Analg.,
July 1, 2009;
109(1):
101 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Huhn, A. Heinen, N. C. Weber, R. P. Kerindongo, G. T. M. L. Oei, M. W. Hollmann, W. Schlack, and B. Preckel
Helium-Induced Early Preconditioning and Postconditioning Are Abolished in Obese Zucker Rats in Vivo
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
600 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Huhn, A. Heinen, N. C. Weber, S. Hieber, M. W. Hollmann, W. Schlack, and B. Preckel
Helium-induced late preconditioning in the rat heart in vivo
Br. J. Anaesth.,
May 1, 2009;
102(5):
614 - 619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Pagel and J. G. Krolikowski
Transient Metabolic Alkalosis During Early Reperfusion Abolishes Helium Preconditioning Against Myocardial Infarction: Restoration of Cardioprotection by Cyclosporin A in Rabbits
Anesth. Analg.,
April 1, 2009;
108(4):
1076 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mio, Y. H. Shim, E. Richards, Z. J. Bosnjak, P. S. Pagel, and M. Bienengraeber
Xenon Preconditioning: The Role of Prosurvival Signaling, Mitochondrial Permeability Transition and Bioenergetics in Rats
Anesth. Analg.,
March 1, 2009;
108(3):
858 - 866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Pagel
Remote Exposure to Xenon Produces Delayed Preconditioning Against Myocardial Infarction In Vivo: Additional Evidence That Noble Gases Are Not Biologically Inert
Anesth. Analg.,
December 1, 2008;
107(6):
1768 - 1771.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Weber, J. Frassdorf, C. Ratajczak, Y. Grueber, W. Schlack, M. W. Hollmann, and B. Preckel
Xenon Induces Late Cardiac Preconditioning In Vivo: A Role for Cyclooxygenase 2?
Anesth. Analg.,
December 1, 2008;
107(6):
1807 - 1813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Pagel, J. G. Krolikowski, P. F. Pratt Jr, Y. H. Shim, J. Amour, D. C. Warltier, and D. Weihrauch
The Mechanism of Helium-Induced Preconditioning: A Direct Role for Nitric Oxide in Rabbits
Anesth. Analg.,
September 1, 2008;
107(3):
762 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Pagel, J. G. Krolikowski, P. F. Pratt Jr, Y. H. Shim, J. Amour, D. C. Warltier, and D. Weihrauch
Inhibition of Glycogen Synthase Kinase or the Apoptotic Protein p53 Lowers the Threshold of Helium Cardioprotection In Vivo: The Role of Mitochondrial Permeability Transition
Anesth. Analg.,
September 1, 2008;
107(3):
769 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|